1 / 6

Gram-Negative Bacterial Infection Market - Current and Future Threats

The emergence and proliferation of highly resistant gram-negative bacteria is a major concern given the limited number of antimicrobial agents that are currently available to combat these organisms.<br><br>READ more: https://www.tmrresearch.com/gram-negative-bacterial-infection-market<br><br>View SAMPLE Report: https://www.tmrresearch.com/sample/sample?flag=B&rep_id=94

Pooja63
Télécharger la présentation

Gram-Negative Bacterial Infection Market - Current and Future Threats

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Gram-Negative Bacterial Infection Market Global Industry Analysis, Size, Share, Analysis, Growth, Forecast 2021 - 2031 Trends, and TMR Research www.tmrresearch.com

  2. Gram-Negative Bacterial Infection Market 1MARKETOVERVIEW Worldwide, antimicrobial resistance is a soaring concern for a range of diseases, especially for enteric fever, respiratory tract infections, and various infections related with gram-negative bacilli (GNB). An upsurge in antibiotic resistance is mainly due to indiscriminate and inappropriate use of antibiotics and a marked decline in the development of efficacious antimicrobial agents. TMR Research www.tmrresearch.com

  3. Gram-Negative Bacterial Infection Market 2KEY TRENDS On the basis of type of infection, the global gram-negative bacterial infection market can be segmented into wound or surgical site infections, pneumonia, urinary tract infections, bloodstream infections, and meningitis. Pneumonia is the most common disease caused gram-negative bacteria followed by urinary tract infections. According to a report by the World Health Organization (WHO), this disease killed 920 136 children under the age of 5 in 2015. TMR Research www.tmrresearch.com

  4. Gram-Negative Bacterial Infection Market 3REGIONAL ASSESSMENT In terms of treatment, the global gram-negative bacterial infection market can be divided into Carbapenems, Colistin, Tigecyclin, Sulbactam, Doxycycline, and Rifampin. The demand for carbapenes is high forthe treatment of gram-negative bacterial infections, particularly pneumonia. Some of the most commonly used carbapenes for the treatment of pneumonia are meropenem, imipenem, and doripenem. Sulbactamismajorlyusedfortreatmentofmeningititis. TMR Research www.tmrresearch.com

  5. Gram-Negative Bacterial Infection Market 4COMPETITVE ANALYSIS Some of the key players in the gram-negative bacterial infection market are Baxter International Inc., Sanofi- Aventis, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Company Therapeutics, Dainippon Sumitomo Pharma Co., Ltd., Rib-X Pharmaceuticals, Inc. and Targeted Genetics Corporation. Limited, Nektar TMR Research www.tmrresearch.com

  6. TMR Research www.tmrresearch.com Sample Discount Check link in description

More Related